Chicago, IL, United States of America

Akiko Koide

This inventor holds 8 USPTO granted patents. Top assignees: The University of Chicago, Novartis Ag, University of Rochester. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Koide. Retrieved from https://idiyas.com/inventor/akiko-koide-z8i5qowo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 62.5

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Akiko Koide: Innovator in Thermophilic Fibronectin Type III Monobodies

Introduction

Akiko Koide is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of biochemistry. With a total of eight patents to her name, she has made remarkable advancements in the development of binding proteins that exhibit improved stability properties.

Latest Patents

Her latest patents focus on methods and compositions involving thermophilic fibronectin type III (FN3) monobodies. The current applications describe various compositions and methods for the production of FN3-based binding proteins with enhanced stability. These innovations include polypeptides that comprise a variant fibronectin type III (FN3) domain, which may contain one or more amino acid substitutions or insertions in either a loop region or a non-loop region of FN3.

Career Highlights

Throughout her career, Akiko has worked with esteemed institutions such as the University of Chicago and the University of Rochester. Her work has significantly impacted the scientific community, particularly in the area of protein engineering.

Collaborations

Some of her notable coworkers include Shohei Koide and Shun-Ichi Tanaka, who have collaborated with her on various research projects.

Conclusion

Akiko Koide's innovative work in the field of thermophilic fibronectin type III monobodies showcases her dedication to advancing biochemistry. Her contributions continue to influence the development of stable binding proteins, marking her as a key figure in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…